Back to calendar
ABCL

ABCL—AbCellera Biologics Inc. Common SharesEarnings

NASDAQ·Healthcare
Next earnings report, EPS estimates, and delayed end-of-day quote

Data sourced from Finnhub (quotes, earnings calendar, news) and Yahoo Finance (daily closing prices). Source evidence retrieved Nov 15, 2026 23:07 UTC. No upcoming date available. Read the methodology.

Next report
Not scheduled
No upcoming date
EPS estimate
—
per share
Revenue est.
—
Market cap
$3.6B

ABCL delayed price change and context

ABCL (AbCellera Biologics Inc. Common Shares) — the delayed price is temporarily unavailable. No price move or cause is inferred.

Delayed quote

Loading…

Fetching quote…

Company overview

Industry
Life Sciences Tools & Services
Exchange
NASDAQ
Market cap
$3.6B
Report time
—

AbCellera Biologics Inc. Common Shares is listed on NASDAQ in the healthcare sector. No upcoming earnings date is currently scheduled.

Price history

Loading…

1D
1W
3M
1Y
Fetching price history…

AbCellera Biologics Inc. Common Shares earnings results · Q3 2026

Reported Nov 9, 2026

EPS estimate

$-0.17

EPS actual

$-0.13

Surprise

+24.2%

Price move

-0.3%

Close Nov 9 ($12.50) → close Nov 10 ($12.46) · end-of-day prices

What ABCL’s latest earnings results show

AbCellera Biologics Inc. Common Shares reported EPS of $-0.13 for Q3 2026. This was $0.04 above the $-0.17 consensus estimate. An EPS beat alone does not establish revenue growth, stronger guidance or an attractive valuation.

Source: Finnhub reported EPS and consensus estimates. Fiscal quarter-end dates are not announcement dates. Price reactions use daily closes, not intraday returns.

Recent posts · ABCL

All posts

No blog posts covering ABCL yet.

AI Stock Analysis is a Pro feature

Get an AI-generated breakdown of every earnings setup — beat history, EPS trend, and what to watch into the print.

Unlock with Pro

Earnings history · EPS estimate vs actual

Last 1 quarters · Free preview · Source: Finnhub

QuarterFiscal period endReportedEPS Est.EPS ActualSurprise
Q3 '262026-09-302026-11-09FinnhubRetrieved 2026-11-15 23:07 UTC-0.17-0.13+24.2%

Post-earnings price reaction · last 4 quarters

1-day = close after announcement vs close before. 5-day = close 5 trading days after vs close before. Projection extrapolates average magnitude.

Loading earnings & price history…

AI summary · latest 8-K earnings release

Generated from the latest SEC EDGAR filing

Summarizing 8-K release… first run can take 10–20s.

Catalyst timeline

Upcoming and recent market-moving events for ABCL · plus key macro context

MacroLow8:30 AM ET· Tue Nov 17
US CPI · Headline & Core

Surprise prints repriced rate-cut odds last 3 of 4 releases. Bond yields and rate-sensitive sectors most exposed.

18
AI score
MacroLow2:00 PM ET· Fri Nov 20
FOMC Rate Decision & Dot Plot

Highest-impact macro print of the cycle. SPX implied move 1.4%, semis 2.3%.

19
AI score

Latest news · ABCL

Headlines from the past 14 days · Source: Finnhub

ABCL discussion

0 posts · live
Loading…
Sign in to join the conversation.Sign in

Be respectful. Opinions only — not investment advice. ⌘/Ctrl+Enter to post.

ABCL earnings FAQ

When does ABCL report earnings?
AbCellera Biologics Inc. Common Shares (ABCL) has no upcoming provider date available here. This does not mean the company has not announced one.
What time does ABCL report earnings?
ABCL historically reports during quarterly earnings season. Check the calendar for the confirmed BMO or AMC time for the next print.
What exchange is ABCL listed on?
AbCellera Biologics Inc. Common Shares (ABCL) trades on the NASDAQ in the Healthcare sector.
How can I track ABCL earnings history?
The latest two reported quarters are publicly available. Pro subscribers can access up to eight quarters and deeper analysis.

What to listen for on the ABCL earnings call

Sector- and ticker-specific items active traders track on AbCellera Biologics Inc. Common Shares's quarterly call — beyond the headline EPS and revenue beat.

  • Drug / device segment revenue and pricing
  • Pipeline read-outs and FDA milestones
  • Medical-loss ratio (for payers)
  • Updated full-year guidance range

ABCL peer context

How ABCL compares to other large healthcare names on the calendar.

TickerCompanyExchangeSector
ABCL
ABCL
AbCellera Biologics Inc. Common SharesNASDAQHealthcare
AAPG
AAPG
Ascentage Pharma Group International American Depository SharesNASDAQHealthcare
AARD
AARD
Aardvark Therapeutics IncNASDAQHealthcare
ABBV
ABBV
AbbVie IncNYSEHealthcare
ABEO
ABEO
Abeona Therapeutics IncNASDAQHealthcare

More Healthcare earnings

Related companies in the Healthcare sector

View sector →

About ABCL earnings

AbCellera Biologics Inc. Common Shares (ABCL) is a healthcare company listed on the NASDAQ. No next release date is available here. . Earnings Compass tracks the report time, analyst EPS and revenue consensus, and the post-release price reaction so active traders can size positions and set alerts ahead of the print.

On reporting day, the two numbers that move ABCL most are the headline EPS and the forward guidance. EPS (earnings per share) measures profit per outstanding share; a beat of analyst consensus often triggers price-target upgrades, while a miss can wipe out months of gains in a single session. The forward guidance management issues for the next quarter frequently overrides the headline — a beat-and-guide-down quarter still sells off, and a miss with a stronger outlook can rally. Active traders also watch the whisper number — the unofficial bar ABCL actually has to clear for the stock to rally on the print.

For a step-by-step playbook on parsing the release, see our guides on reading an earnings report and trading earnings season. If you're new to the calendar workflow, the earnings calendar guide covers how to filter the day's reports by sector and market cap to surface the names that actually move your book.

Add ABCL to your watchlist to receive an alert when the date is confirmed and again when results hit. You can also browse the full Healthcare sector page for the rest of the upcoming reports in this group, or the full earnings calendar for everything reporting this week.